K. Seidel, M. Meister, G. J. Dugbartey, M. P. Zijlstra, J. Vinet, E. R. P. Brunt, F. W. van Leeuwen, U. Rub, H. H. Kampinga and W. F. A. den Dunnen (2012) Neuropathology and Applied Neurobiology38, 548558 Cellular protein quality control and the evolution of aggregates in spinocerebellar ataxia type 3 (SCA3) Aims: A characteristic of polyglutamine diseases is the increased propensity of disease proteins to aggregate, which is thought to be a major contributing factor to the underlying neurodegeneration. Healthy cells contain mechanisms for handling protein damage, the protein quality control, which must be impaired or inefficient to permit proteotoxicity under pathological conditions. Methods: We used a quantitative analysis of immunohistoc...
Protein aggregation is a key mechanism involved in neurodegeneration associated with Alzheimer’s, Pa...
The formation of insoluble protein aggregates in neurons is a hallmark of neurodegenerative diseases...
Polyglutamine expansions in certain proteins are the genetic determinants for nine distinct progress...
K. Seidel, M. Meister, G. J. Dugbartey, M. P. Zijlstra, J. Vinet, E. R. P. Brunt, F. W. van Leeuwen,...
AimsPolyglutamine (polyQ) diseases are characterized by the expansion of a polymorphic glutamine seq...
AimsPolyglutamine (polyQ) diseases are characterized by the expansion of a polymorphic glutamine seq...
The polyglutamine (polyQ) diseases are a group of genetically and clinically heterogeneous neurodege...
Protein aggregation is a major pathological hallmark of many neurodegenerative disorders including p...
Spinocerebellar ataxia type 3 or Machado-Joseph disease (SCA3/MID) is a member of the CAG/polyglutam...
Protein misfolding and aggregation characterizes the development of a number of neurodegenerative di...
Neuronal protein aggregates are considered as pathological hallmarks of various human neurodegenerat...
Protein aggregation is a key mechanism involved in neurodegeneration associated with Alzheimer’s, Pa...
The formation of insoluble protein aggregates in neurons is a hallmark of neurodegenerative diseases...
Polyglutamine expansions in certain proteins are the genetic determinants for nine distinct progress...
K. Seidel, M. Meister, G. J. Dugbartey, M. P. Zijlstra, J. Vinet, E. R. P. Brunt, F. W. van Leeuwen,...
AimsPolyglutamine (polyQ) diseases are characterized by the expansion of a polymorphic glutamine seq...
AimsPolyglutamine (polyQ) diseases are characterized by the expansion of a polymorphic glutamine seq...
The polyglutamine (polyQ) diseases are a group of genetically and clinically heterogeneous neurodege...
Protein aggregation is a major pathological hallmark of many neurodegenerative disorders including p...
Spinocerebellar ataxia type 3 or Machado-Joseph disease (SCA3/MID) is a member of the CAG/polyglutam...
Protein misfolding and aggregation characterizes the development of a number of neurodegenerative di...
Neuronal protein aggregates are considered as pathological hallmarks of various human neurodegenerat...
Protein aggregation is a key mechanism involved in neurodegeneration associated with Alzheimer’s, Pa...
The formation of insoluble protein aggregates in neurons is a hallmark of neurodegenerative diseases...
Polyglutamine expansions in certain proteins are the genetic determinants for nine distinct progress...